Composition for Predicting Survival and the Response of a Patient with Myelodysplastic Syndromes to Hypomethylating Agent

摘要

The present invention relates to a composition, a gene panel and a kit for confirming the mutation of gene markers for prediction of survival prognosis and response to treatment of hypomethylated formulations in patients with myelodysplastic syndromes, responsiveness to hypomethylated formulations in patients with myelodysplastic syndromes And a method for providing information for predicting the survival prognosis. The composition for predicting the response and survival prognosis of a hypomethylated formulation of the present invention can provide a more accurate prediction of the prognosis than the existing composition and can provide useful information for determining the treatment direction of the patient with the myelodysplastic syndrome.